Related Experiment Video
Updated: Apr 25, 2026
12:21
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
14.2K
MicroRNAs in kidney transplantation
Julia Wilflingseder1, Roman Reindl-Schwaighofer2, Judith Sunzenauer2
1Department of Nephrology and Dialysis, Medical University Vienna, Vienna, Austria Department of Nephrology, KH Elisabethinen, Linz, Austria.
Summary
Non-coding RNAs (ncRNAs), especially microRNAs (miRNAs), are revolutionizing medicine. Monitoring miRNA profiles in kidney transplant patients offers new diagnostic and therapeutic strategies for rejection and infections.
Area of Science:
- Biomedical Science
- Molecular Biology
- Genetics
Background:
- Non-coding RNAs (ncRNAs) have emerged from obscurity to reveal critical biological functions.
- MicroRNAs (miRNAs), a class of short ncRNAs, are key regulators of gene expression and cellular processes.
- ncRNAs are increasingly recognized for their roles in disease pathogenesis and as potential therapeutic targets.
Purpose of the Study:
- To review the impact of the ncRNA revolution on kidney transplantation.
- To highlight the diagnostic and prognostic potential of miRNAs in renal allograft recipients.
- To discuss the therapeutic applications of miRNA-targeted strategies in transplantation.
Main Methods:
- Review of current literature on ncRNAs and kidney transplantation.
- Analysis of studies investigating miRNA profiling for diagnostics and prognostics.
- Examination of preclinical and clinical data on anti-miRNA therapies.
Main Results:
- miRNAs are implicated in kidney transplant complications like ischemia-reperfusion injury, rejection, and viral infections.
- Genome-wide miRNA profiling of biological fluids shows promise for monitoring transplant recipients.
- Antisense oligonucleotide-based suppression of miRNAs has demonstrated success in experimental and clinical settings for viral clearance.
Conclusions:
- miRNA profiling is poised to become an integral part of future renal allograft recipient monitoring.
- Targeted anti-miRNA therapies represent a novel and effective therapeutic avenue for kidney transplantation.
- The ncRNA field holds significant promise for advancing personalized medicine in organ transplantation.
Related Concept Videos
01:26Kidney Transplant II: Surgical Procedure
917
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
917
01:16Kidney Transplant III: Nursing Management
625
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
625
01:28Kidney Transplant I: Introduction
818
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
818
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
557
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
557